Develops a self-powered biosensor that detects trace cisplatin on-site, indicating enhanced sensitivity for environmental monitoring.
We develop a multiplexed self-powered cisplatin sensor based on catalytic repurposing. Cisplatin is reengineered as a catalyst, amplifying dual-output signals of electrical and smartphone-readable colorimetric outputs. Sensitivity increases 1,000-fold with...
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: